Revolution Medicines Inc
NASDAQ:RVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
P
|
Phoenix Mills Ltd
BSE:503100
|
IN |
|
U
|
United Rentals Inc
F:UR3
|
US |
|
Adapthealth Corp
NASDAQ:AHCO
|
US |
|
Borr Drilling Ltd
F:B2W
|
BM |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XMUN:MOH
|
FR |
|
T
|
Ternium SA
BMV:TX
|
LU |
|
Standard Bank Group Ltd
F:SKC2
|
ZA |
|
C
|
Citigroup Inc
SWB:TRVC
|
US |
|
T
|
Thomson Reuters Corp
LSE:0Q89
|
CA |
|
C
|
Canadian Tire Corporation Ltd
TSX:CTC
|
CA |
|
W
|
W.p. Carey Inc
LSE:0LS8
|
US |
|
Z
|
Zalando SE
XHAN:ZAL
|
DE |
|
U
|
UPM-Kymmene Oyj
DUS:RPL
|
FI |
|
W
|
Warner Bros Discovery Inc
DUS:J5A
|
US |
|
Novartis AG
SIX:NOVN
|
CH |
|
Benefit Systems SA
F:3ZV
|
PL |
|
Kuaishou Technology
LSE:0A74
|
CN |
|
Toyo Seikan Group Holdings Ltd
TSE:5901
|
JP |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
Navigator Company SA
OTC:POELF
|
PT |
|
Advanced Energy Industries Inc
NASDAQ:AEIS
|
US |
Bankruptcy Probability
Revolution Medicines Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Revolution Medicines Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
230.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Revolution Medicines Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Revolution Medicines Inc has total debt of 268.4m USD. This includes both short-term (0 USD) and long-term (268.4m USD) debt.
You can find a full breakdown on its Balance Sheet.